Leading Psychedelic Pharmaceutical Company MindMed Forms New Board Committee To Evaluate Acquisitions And Scientific Collaborations

John Hopkins professor and psychedelics expert Matthew Johnson to act as senior advisor to committee NEW YORK, March 12, 2020 -- (Healthcare Sales & Marketing Network) -- Mind Medicine (MindMed) Inc. ("MindMed") has formed a Technology Evalua... Biopharmaceuticals, Neurology, Personnel Mind Medicine, MindMed, ibogaine

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2045826

Source: HSMN NewsFeed - March 12, 2020 Category: Pharmaceuticals Source Type: news